Cargando…
A Novel Finding of Lichenoid Drug Reaction From Ibrutinib Therapy
Ibrutinib is Burton’s tyrosine kinase inhibitor used in the treatment of chronic lymphocytic leukemia and other conditions. This drug has been generally thought to be well tolerated, although studies have identified a few distinct adverse effects, including gastrointestinal discomfort, nausea, diarr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941677/ https://www.ncbi.nlm.nih.gov/pubmed/35371696 http://dx.doi.org/10.7759/cureus.22433 |